Fujino, Hatsue
Tanaka, Mio
Imamura, Michio http://orcid.org/0000-0002-0745-991X
Morio, Kei
Ono, Atsushi
Nakahara, Takashi
Murakami, Eisuke
Kawaoka, Tomokazu
Takahashi, Shoichi
Miki, Daiki
Tsuge, Masataka
Hiramatsu, Akira
Aikata, Hiroshi
Hayes, C. Nelson
Chayama, Kazuaki
Funding for this research was provided by:
Japan Agency for Medical Research and Development (18fk0210020h0002)
Article History
Received: 10 June 2019
Accepted: 11 October 2019
First Online: 24 October 2019
Ethics approval and consent to participate
: All participants provided written informed consent to participate in the study according to the process approved by the ethical committee of Hiroshima University and conforming to the ethical guidelines of the Declaration of Helsinki.
: Not applicable. The authors declare that no patient data (details, images or videos relating to individual participants) are included in this article.
: Michio Imamura has received research funding from Bristol-Myers Squibb. Kazuaki Chayama has received honoraria from Bristol-Myers Squibb, MSD K.K., AbbVie Inc., Gilead Sciences and Dainippon Sumitomo Pharma and research funding from Dainippon Sumitomo Pharma, MSD K. K and AbbVie Inc..